1. AB0034 IFN-Gamma-Producing VZV-Specific CD4 T-Cells in Patients with Rheumatoid Arthritis (RA). (10th June 2014) Authors: Almanzar, G.; Bienenstein, E.; Höfner, K.; Schmalzing, M.; Tony, H.-P.; Liese, J.; Prelog, M. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 815 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0148 T-cell phenotype and intracellular cytokine-production in t-cells in patients with systemic sclerosis. (23rd January 2014) Authors: Klein, M.; Almanzar, G.; Höfner, K.; Schmalzing, M.; Kleinert, S.; Tony, H.-P.; Benoit, S.; Hamm, H.; Goebeler, M.; Prelog, M. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0189 Anti-Modified Protein Antibody Response Pattern Influences The Risk for Disease Relapse in Rheumatoid Arthritis Patients Tapering Disease Modifying Anti-Rheumatic Drugs. (15th July 2016) Authors: Figueiredo, C.; Bang, H.; Cobra, J.F.; Englbrecht, M.; Hueber, A.J.; Haschka, J.; Manger, B.; Kleyer, A.; Reiser, M.; Finzel, S.; Tony, H.-P.; Kleinert, S.; Wendler, J.; Schuch, F.; Ronneberger, M.; Feuchtenberger, M.; Fleck, M.; Manger, K.; Ochs, W.; Schmitt-Haendle, M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 961 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0252 Loosing das28-esr, but staying in boolean remission- is it possible? data from the prospective, randomised retro trial on rheumatoid arthritis patients in stable remission. (12th June 2018) Authors: Erhard, J.; Hagen, M.; Englbrecht, M.; Haschka, J.; Reiser, M.; Kleyer, A.; Hueber, A.J.; Manger, B.; Figueiredo, C.; Cobra, J.F.; Tony, H.-P.; Finzel, S.; Kleinert, S.; Wendler, J.; Schuch, F.; Ronneberger, M.; Feuchtenberger, M.; Fleck, M.; Manger, K.; Ochs, W. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0270 Treatment response to rituximab in combination with leflunomide is influenced by anticcp status in active rheumatoid arthritis: results from a multicenter randomised placebo-controlled investigator initiated clinical trial in active rheumatoid arthritis (AMARA-STUDY). (12th June 2018) Authors: Köhm, M.; Rossmanith, T.; Alten, R.; Aringer, M.; Backhaus, M.; Burmester, G.; Feist, E.; Herrmann, E.; Kellner, H.; Lehn, A.; Müller-Ladner, U.; Rubbert-Roth, A.; Tony, H.-P.; Wassenberg, S.; Burkhardt, H.; Behrens, F. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0437 Adalimumab therapy results in sustained response in rheumatoid arthritis patients over 5 years: the german noninterventional agil study. (12th June 2018) Authors: Behrens, F.; Schmalzing, M.; Koehm, M.; Schwaneck, E.C.; Greger, G.; Mosch, T.; Burkhardt, H.; Tony, H.-P. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB1344 Presence of echocardiographic criteria for hfpef multiplies the risk for death and cardiovascular events in patients with rheumatic diseases. (12th June 2018) Authors: Kleinert, S.; Morbach, C.; Tony, H.-P.; Angermann, C.E.; Stoerk, S.; Breunig, M. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1760 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0098 Hepatic safety in patients with rheumatoid arthritis who received isoniazid for latent tuberculosis: post-hoc analysis from phase 3 baricitinib studies. (12th June 2018) Authors: Hsieh, T.-Y.; Huang, W.-N.; Tony, H.-P.; Balsa, A.; Winthrop, K.; Harigai, M.; Dickson, C.; Wu, W.-S.; de la Torre, I.; Liao, R.; Chen, L.; Kumar, S.; Combe, B. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0117 Tocilizumab use directly after sdmard failure shows higher response rates and a longer treatment duration. (12th June 2018) Authors: Behrens, F.; Biewer, W.A.; Burmester, G.-R.; Feuchtenberger, M.; Flacke, J.-P.; Hofmann, M.; Kästner, P.; Kellner, H.; Klopsch, T.; Kühne, C.; Tony, H.-P.; Amberger, C. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0150 Depression, Inflammation and Mortality in Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Kleinert, S.; Marx, A.; Faller, H.; Tony, H.-P.; Feuchtenberger, M.; Kneitz, C.; Lehmann, S.; Angermann, C.; Ertl, G.; Störk, S.; Breunig, M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗